AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Early Detection of Renal Abnormalities in Metabolically Healthy and Unhealthy Weight Excess"

Recruitingn/aAges 18 Years - 60 YearsAllIstituto Auxologico Italiano
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Overweight and obesity are increasingly prevalent worldwide. Weight excess increases the risk of in developing the metabolic syndrome, which is composed by a set of cardiometabolic risk factors such as abdominal adiposity, dyslipidemia, high blood pressure and elevated fasting glucose levels. Obesity and the metabolic syndrome are known to be risk factors for the development of chronic kidney disease. It is not clear however, whether they can be considered independent risk factors for impaired renal function and renal damage. Whereas obesity may represent an independent risk factor for renal damage, it is not clear yet if the contemporaneous presence of obesity and metabolic alterations is associated with an additional increase in the risk. It may be important to understand the relationship between obesity, metabolic syndrome and renal health, as treatment strategies may be different fo

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 60 years * BMI at least 25 kg/m2 Exclusion Criteria: * Pregnancy or breastfeeding * Diabetes mellitus * Renal disease * Systemic autoimmune diseases with possible renal involvement * Agonistic physical activity * Heart failure * Pharmacologcal treatment with RAAS-inhibitors, sartans, thiazide diuretics, loop diuretics * Urinary tract infection
๐Ÿ’Š

What it tests

  • Diet
๐Ÿ“

Where

2 sites
Istituto Auxologico Italiano, Cittร  Studi ICANS
Milan, Italy
Programma Infradipartimentale di Dietoterapia nel Trapianto e nell' Insufficienza Renale Cronica, DAI di Medicina Interna ad Indirizzo Specialistico, del Policlinico Federico II di Napoli
Naples, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy